Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/08/003871
CTRI/2013/08/003871
Recruiting
未知

Population pharmacokinetics and pharmacogenetics of tacrolimus in renal transplant patients - POPTAC

Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Renal transplant patients on tacrolimus

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Renal transplant patients on tacrolimus
Sponsor
Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER
Enrollment
30
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER

Eligibility Criteria

Inclusion Criteria

  • •Subjects Age 18 to 65 years and of either gender.
  • •Post renal transplant patients on treatment with tacrolimus

Exclusion Criteria

  • •Subjects on parenteral immunosuppressants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Drug levels of Mycophenolic acid and the genetic mutations that affects these blood levels in patients with autoimmune diseases taking durg mycophenolate mofetil (MMF)Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified
CTRI/2023/03/050985Seth GS Medical College and KEM Hospital
Completed
Not Applicable
Population pharmacokinetics and pharmacodynamics of sorafenib in hepatocellular carcinoma patients with Child Pugh B liver cirrhosishepatocellular carcinomaliver cancer1001965410019815
NL-OMON44524Academisch Medisch Centrum45
Completed
Not Applicable
Study about the relationship between ramosetron dose, plasma concentration and antiemetic effectNot Applicable
KCT0001500Asan Medical Center51
Recruiting
Not Applicable
Population pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin after intravenous administration in pediatric patientsmultidrug resistant gram negative bacteria (MDR GNB)intravenous colistinPopulation pharmacokineticscolistimethate sodium (CMS)colistinintravenouspediatric patients
TCTR20181001003Graduate School, Chiang Mai University60
Not yet recruiting
Not Applicable
Treatment with Tapentadol in Cancer PatientsHealth Condition 1: G893- Neoplasm related pain (acute) (chronic)
CTRI/2020/11/029206Manipal Academy of Higher Education